Review
Copyright ©The Author(s) 2021.
World J Hepatol. Mar 27, 2021; 13(3): 270-290
Published online Mar 27, 2021. doi: 10.4254/wjh.v13.i3.270
Figure 1
Figure 1 Typical liver regeneration. A: Priming phase. Mature hepatocytes undergo the G0-G1 transition driven by interleukin-6 and tumor necrosis factor-α. Sinusoid endothelial cells produce urokinase plasminogen activator in response to increased blood pressure. Urokinase plasminogen activator activates matrix metalloproteinase, resulting in extracellular matrix remodeling and the release of growth factors; B: Proliferative phase. Numerous factors, including Wnt-ligands, growth factors and bile acids, lead to the transcription of cyclin-dependent kinase and cyclins, resulting in the S-M transition and hepatocyte proliferation. Bile acids also suppress the synthesis of inflammatory cytokines by Kupffer cells; C: Termination phase. Different factors, primarily tumor necrosis factor-β family members, initiate the cell cycle arrest of hepatocytes and reversion to the G0 phase and cause the apoptosis of newly formed cells to correct the excessive regenerative response. TNF-α: Tumor necrosis factor-α; IL-6: Interleukin-6; MMP: Matrix metalloproteinase; KC: Kupffer cells; SEC: Sinusoid endothelial cells; HGF: Hepatocyte growth factor; EGFR: Epidermal growth factor receptor; MAPK: Mitogen-activated protein kinase.
Figure 2
Figure 2 Progenitor-dependent liver regeneration. In case of excessive acute injury or chronic liver diseases, hepatic progenitor cell activation occurs in response to different inflammatory cytokines, including tumor necrosis factor-like weak inducer of apoptosis. Depending on the type of stimulus, hepatic progenitor cells can differentiate into biliary epithelial cells or hepatocytes to restore the liver mass. PV: Portal vein; HA: Hepatic artery; CV: Central vein; BECs: Biliary epithelial cells; HPCs: Hepatic progenitor cells; HNFs: Hepatocyte nuclear factors.